September 01, 2023

VIEWPOINT FROM THE EDITOR

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

May 17, 2024

Watch: John Oliver Dishes on KFF Health News’ Opioid Settlements Series

Recent reporting and analysis show how opioid settlement funds are being allocated by state and local governments in the US, shedding light on the significant restitution efforts by manufacturers, distributors, and retailers.

KFF Health News

May 31, 2024

The Chicken and Egg Problem of Fighting Another Flu Pandemic

Researchers express concern over the reliance on egg-based technology for flu vaccine production amid potential pandemic threats.

KFF Health News

March 01, 2024

AI’s Impact + Influence

Three thought leaders unpack their professional perspectives on how the dawn of artificial intelligence will impact vision care today.

Eyecare Business

January 01, 2024

The Metaverse is Coming

In-person meetings may be here to stay, but the metaverse is providing a nice complement.

Ophthalmology Management

September 24, 2024

Clobetasol Soon to be Available in the US

A new topical ophthalmic steroid for postoperative inflammation and pain is now available to US patients.

Conexiant

September 01, 2023

From the Editor: Medicare Contractors Attack Vulnerable Glaucoma Patients

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Glaucoma Physician

May 23, 2024

Clues From Bird Flu’s Ground Zero on Dairy Farms in the Texas Panhandle

In early February, dairy farmers in the Texas Panhandle noticed sick cattle, leading to the discovery of a highly pathogenic strain of bird flu, H5N1, which has now spread to eight states, raising concerns about its potential to mutate and pose a risk to humans.

KFF Health News

July 09, 2024

Eye Implant Reintroduced in U.S. After Recall

Genentech re-launches Susvimo eye implant in the U.S. after addressing recall issues.

Reuters